Multiple sclerosis (MS) is an idiopathic chronic inflammatory disease that strikes the Central Nervous System (CNS). Moreover, it is the most diffused disabling neurologic disease, in fact about 12 * 103 new diagnoses/year arise in the United States alone. It is clear that the development of a MS predictive system is necessary, in order to have a reliable biostatistics tool to forecast the incidence value with a significant degree of accuracy in both time and space. Since the reached prevision time was equal to 1 year (namely 2019), the model was ameliorated by unpacking the considered and refined time period. The theoretical MS incidence for 2023 in Italy was calculated to be 12.17% (± 2.04), with a theoretical accuracy of 99.35% (± 1.02). It can be stated E-MuSER (Enhanced Multiple Sclerosis Expected Rate) could reach a higher dependability degree, as well as theoretical accuracy, with the respect to the previous model. Its efficiency will be assessed at the end of year 2023.
|Titolo:||E-MuSER (Enhanced Multiple Sclerosis Expected Rate): a technical improvement|
|Data di pubblicazione:||2019|
|Appare nelle tipologie:||01.01 - Articolo su rivista|
File in questo prodotto:
|2019 E-Muser (Enhanced Multiple Sclerosis Expected Rate) A Technical Improvement.pdf||Documento in versione editoriale||Open Access Visualizza/Apri|